NCT05782361 2025-08-20POTENTInstitute of Cancer Research, United KingdomPhase 1 Recruiting19 enrolled
NCT03492437 2023-08-07Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran EtexilateMerck KGaA, Darmstadt, GermanyPhase 1 Completed20 enrolled 14 charts